Stay updated on ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial
Sign up to get notified when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.

Latest updates to the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA newer revision tag v3.6.3 was added and an older tag v3.6.0 was removed, indicating a minor version update to the page's underlying system or documentation.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a note that no more participants are being recruited and includes a revision tag (v3.6.0). Concurrently, multiple enrollment-related sections were deleted or collapsed, changing how participant counts and enrollment details are presented on the results page.SummaryDifference1%

- Check32 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor backend update. There are no visible changes to the page content or study results.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now references Revision: v3.5.4, replacing Revision: v3.5.3, indicating a minor revision update to the page's release notes.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page’s “Revision” (site/system version) label was updated from v3.5.0 to v3.5.3, reflecting a backend or platform update rather than a change to the displayed study results.SummaryDifference0.0%

- Check99 days agoChange DetectedKey results data and descriptions were removed from the Study Results page, including participant counts by timepoint and arm, and several primary/secondary outcomes (LDL-C, PCSK9, triglycerides, ApoB) along with adverse events.SummaryDifference0.9%

Stay in the know with updates to ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.